SomnoMed Limited (SOMNF)

USD 0.17

(0.0%)

Market Cap (In USD)

36.73 Million

Revenue (In USD)

91.65 Million

Net Income (In USD)

-12.24 Million

Avg. Volume

96.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.13-0.39
PE
-
EPS
-
Beta Value
1.382
ISIN
AU000000SOM1
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Ms. Amrita Blickstead BME, M.B.A.
Employee Count
-
Website
https://somnomed.com/au/
Ipo Date
2010-10-15
Details
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.